Grace Therapeutics, Total Asset vs. Total Debt
| GRCE Stock | 3.44 0.16 4.88% |
Grace Therapeutics, Total Assets |
|
For Grace Therapeutics, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Grace Therapeutics, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Grace Therapeutics, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Grace Therapeutics,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Grace Therapeutics, over time as well as its relative position and ranking within its peers.
Grace |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Grace Therapeutics,. If investors know Grace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Grace Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Grace Therapeutics, is measured differently than its book value, which is the value of Grace that is recorded on the company's balance sheet. Investors also form their own opinion of Grace Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Grace Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grace Therapeutics,'s market value can be influenced by many factors that don't directly affect Grace Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grace Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Grace Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grace Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Grace Therapeutics, Total Debt vs. Total Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Grace Therapeutics,'s current stock value. Our valuation model uses many indicators to compare Grace Therapeutics, value to that of its competitors to determine the firm's financial worth. Grace Therapeutics, is one of the top stocks in total asset category among its peers. It also is rated as one of the top companies in total debt category among its peers making up about 0.16 of Total Debt per Total Asset. The ratio of Total Asset to Total Debt for Grace Therapeutics, is roughly 6.34 . At present, Grace Therapeutics,'s Total Assets are projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Grace Therapeutics, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Grace Total Debt vs. Total Asset
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Grace Therapeutics, |
| = | 73.3 M |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Grace Therapeutics, |
| = | 11.56 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Grace Total Debt vs Competition
Grace Therapeutics, is rated as one of the top companies in total debt category among its peers. Total debt of Biotechnology industry is currently estimated at about 237.83 Million. Grace Therapeutics, holds roughly 11.56 Million in total debt claiming about 5% of stocks in Biotechnology industry.
Grace Therapeutics, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Grace Therapeutics,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Grace Therapeutics, will eventually generate negative long term returns. The profitability progress is the general direction of Grace Therapeutics,'s change in net profit over the period of time. It can combine multiple indicators of Grace Therapeutics,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 911 K | 956.5 K | |
| Interest Income | 911 K | 956.5 K | |
| Operating Income | -11.4 M | -11.9 M | |
| Net Loss | -12.9 M | -13.5 M | |
| Income Before Tax | -14.7 M | -15.4 M | |
| Total Other Income Expense Net | -4.2 M | -4.4 M | |
| Net Loss | -12.9 M | -13.5 M |
Grace Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Grace Therapeutics,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Grace Therapeutics, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Grace Therapeutics,'s important profitability drivers and their relationship over time.
| Total Asset vs Net Income | ||
| Cash Flow From Operations vs Total Debt | ||
| Total Asset vs Retained Earnings | ||
| Working Capital vs Total Debt |
Use Grace Therapeutics, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Grace Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grace Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Grace Therapeutics, Pair Trading
Grace Therapeutics, Pair Trading Analysis
The ability to find closely correlated positions to Grace Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Grace Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Grace Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Grace Therapeutics, to buy it.
The correlation of Grace Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Grace Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Grace Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Grace Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Grace Therapeutics, position
In addition to having Grace Therapeutics, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Climate Change Thematic Idea Now
Climate Change
Large and medium sized entities that are committing to fully or partially replace some traditional services or products with renewables sources of energy in order to combat global climate change. The Climate Change theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Climate Change Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
To fully project Grace Therapeutics,'s future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Grace Therapeutics, at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Grace Therapeutics,'s income statement, its balance sheet, and the statement of cash flows.